安克生醫股份有限公司 Approved
最後更新時間 2025/07/15 , 02:49 AM
最後更新時間 2025/07/15 , 02:49 AM
負責人
Li,Yi-Li
統一編號
24316471
成立日期
2008/12/26
資本額
NT$1,000,000,000
實收資本額
NT$633,329,000
股票代號
4188
電話
02-27136227
地址
5F, No. 167, Fusing N. Rd., Songshan Dist., Taipei City, 105, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Li,Yi-Li Chairman 0.92%
Li,Yi-Ling Vice Chairman 34.98% PHYTOHEALTH CORPORATION
Li,Cheng-Jia Director 34.98% PHYTOHEALTH CORPORATION
Zhang,Jin-Jian Director 4.58%
Xu,Jin-Chuan Director 6.31% MAYWUFA COMPANY LTD.
Chen,Wei-De Director 34.98% PHYTOHEALTH CORPORATION
Qiu,Shu-Shi Director 0.07% REN YU Ltd.
Wang,Zai-Bin Director 6.31% MAYWUFA COMPANY LTD.
Ceng,Tian-Ci Director 0.07% REN YU Ltd.
Zhang,Qing-Tian Independent Director 0.00%
Huang,Wen-Hong Independent Director 0.00%
Li,Xue-Yu Independent Director 0.00%
Lin,Se-Yi Independent Director 0.00%
營業項目
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • 公司歷程
  • Change Person in Charge to Li,Yi-Li
    2020/11/23
  • Change Capital to 1,000,000,000
    2016/07/26
  • Change Capital to 500,000,000
    2013/11/22
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 6,780 53,105 65,256
    Operating cost 4,379 20,171 24,232
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 2,401 32,934 41,024
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 2,401 32,934 41,024
    Operating expenses 23,703 97,598 95,009
    Other gain (loss), net - - -
    Operating profit (loss) -21,302 -64,664 -53,985
    Non-operating income and expenses 1,961 11,788 10,836
    Net profit (loss) before tax -19,341 -52,876 -43,149
    Income tax expense (benefits) 0 0 0
    Net profit (loss) of ongoing business for the current period -19,341 -52,876 -43,149
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -19,341 -52,876 -43,149
    Other comprehensive profit (loss), net -5,134 5,116 -681
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -24,475 -47,760 -43,830
    Net profit (loss) attributable to owners of parent company -15,579 -50,577 -45,314
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -3,762 -2,299 2,165
    Comprehensive profit (loss) attributable to owners of parent company -20,713 -45,461 -45,995
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -3,762 -2,299 2,165
    Basic earnings per share (yuan) 0 0 0
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -14,968 -51,850 -41,599
    Net cash inflows (outflows) from investing activities 18,096 -185,428 27,311
    Net cash inflow (outflow) from financing activities -1,315 225,376 -3,098
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period 1,813 -11,902 -17,386
    Beginning balance of cash and cash equivalents 17,756 29,658 47,044
    Ending balance of cash and cash equivalents 19,569 17,756 29,658
    項目 2025 2024 2023
    Current asset 452,330 418,085 325,893
    Non-current asset 210,466 276,788 186,753
    Total asset 662,796 694,873 512,646
    Current liability 18,998 25,143 24,419
    Non-current liability 4,430 6,012 10,279
    Total liability 23,428 31,155 34,698
    share capital 633,329 633,329 533,306
    Equity - secruity token - - -
    capital reserve 141,648 141,523 8,016
    retained earning -212,942 -199,320 -148,743
    Other equity -13,971 -6,880 -11,996
    Treasury stock - - -
    Total equity attributable to owners of parent company 548,064 568,652 380,583
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 91,304 95,066 97,365
    Total Equity 639,368 663,718 477,948
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 45,000
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 8 8 7
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • AmCAD-UT
  • 乳安偵
  • 安克細偵
  • 安克呼止偵
  • iSONO
  • 安克彩優
  • AmCADU
  • 安克甲狀偵
  • 安克甲狀診
  • 安克彩優(簡體字)
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。